ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 128 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,971 | -99.9% | 601,005 | 0.0% | 0.01% | -22.2% |
| Q3 2022 | $2,272,000 | -51.9% | 601,005 | -0.9% | 0.01% | -50.0% |
| Q2 2022 | $4,723,000 | -30.3% | 606,269 | -16.9% | 0.02% | -5.3% |
| Q1 2022 | $6,779,000 | -77.9% | 729,686 | -62.6% | 0.02% | -78.7% |
| Q4 2021 | $30,713,000 | +13.7% | 1,948,815 | +29.1% | 0.09% | +3.5% |
| Q3 2021 | $27,024,000 | +16.1% | 1,509,728 | +0.9% | 0.09% | +8.9% |
| Q2 2021 | $23,277,000 | +106.5% | 1,496,924 | +93.5% | 0.08% | +9.7% |
| Q2 2020 | $11,273,000 | +62.5% | 773,690 | +83.7% | 0.07% | +63.6% |
| Q4 2019 | $6,937,000 | -59.6% | 421,218 | +1.4% | 0.04% | -74.1% |
| Q3 2018 | $17,182,000 | +96.7% | 415,520 | +74.8% | 0.17% | +68.3% |
| Q2 2018 | $8,734,000 | +63.2% | 237,668 | +73.2% | 0.10% | +44.3% |
| Q1 2018 | $5,352,000 | – | 137,236 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,610,000 | 11.42% |
| Redmile Group, LLC | 6,048,123 | $9,737,478 | 0.37% |
| Baupost Group | 9,773,616 | $15,736 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 170,000 | $273,700 | 0.27% |
| MAVERICK CAPITAL LTD | 6,290,713 | $10,128,048 | 0.22% |
| 683 Capital Management, LLC | 1,000,000 | $1,610,000 | 0.12% |
| WASATCH ADVISORS LP | 8,283,981 | $13,337,209 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $845,250 | 0.08% |
| STALEY CAPITAL ADVISERS INC | 750,000 | $1,207,500 | 0.06% |
| XTX Topco Ltd | 136,841 | $220,314 | 0.04% |